PMC:7195088 / 58842-59734
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1752 | 53-61 | Species | denotes | patients | Tax:9606 |
1753 | 67-75 | Species | denotes | SARS-CoV | Tax:694009 |
1754 | 231-239 | Species | denotes | patients | Tax:9606 |
1755 | 591-599 | Species | denotes | patients | Tax:9606 |
1756 | 605-613 | Species | denotes | MERS-CoV | Tax:1335626 |
1757 | 837-845 | Species | denotes | MERS-CoV | Tax:1335626 |
1758 | 859-867 | Species | denotes | patients | Tax:9606 |
1759 | 646-660 | Chemical | denotes | hydrocortisone | MESH:D006854 |
1760 | 38-52 | Disease | denotes | critically ill | MESH:D016638 |
1761 | 82-100 | Disease | denotes | MERS-CoV infection | MESH:D018352 |
1762 | 200-214 | Disease | denotes | CoV-1–infected | MESH:D018352 |
1763 | 216-230 | Disease | denotes | critically ill | MESH:D016638 |
1764 | 284-293 | Disease | denotes | mortality | MESH:D003643 |
1765 | 433-453 | Disease | denotes | secondary infections | MESH:D060085 |
1766 | 576-590 | Disease | denotes | critically ill | MESH:D016638 |
1767 | 742-751 | Disease | denotes | mortality | MESH:D003643 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T93 | 846-849 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T94 | 869-886 | Body_part | denotes | respiratory tract | http://purl.org/sig/ont/fma/fma265130 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T48 | 869-886 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T335 | 67-75 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T336 | 91-100 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T337 | 195-203 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T338 | 443-453 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T325 | 152-153 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T326 | 533-534 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T327 | 637-638 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T328 | 719-720 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T2436 | 19-34 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T79577 | 241-255 | Chemical | denotes | corticosteroid | http://purl.obolibrary.org/obo/CHEBI_50858 |
T14063 | 482-496 | Chemical | denotes | corticosteroid | http://purl.obolibrary.org/obo/CHEBI_50858 |
T69694 | 646-660 | Chemical | denotes | hydrocortisone | http://purl.obolibrary.org/obo/CHEBI_17650 |
T25050 | 766-780 | Chemical | denotes | corticosteroid | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T431 | 0-148 | Sentence | denotes | Data on the use of corticosteroids in critically ill patients with SARS-CoV-1 and MERS-CoV infection are available, albeit with conflicting results. |
T432 | 149-397 | Sentence | denotes | In a retrospective observational study of 152 SARS-CoV-1–infected, critically ill patients, corticosteroid therapy was found to reduce mortality and shorten the length of hospital stay (odds ratio 0.08, 95% confidence intervals 0.01–0.97, p 0.046). |
T433 | 398-517 | Sentence | denotes | The study did not report increased secondary infections or other complications with corticosteroid administration [64]. |
T434 | 518-752 | Sentence | denotes | Conversely, in a retrospective observational study on 309 critically ill patients with MERS-CoV, the administration of a median hydrocortisone equivalent dose of 300 mg per day was not associated with a difference in 90-day mortality. |
T435 | 753-892 | Sentence | denotes | In addition, corticosteroid administration was associated with delayed clearance of MERS-CoV RNA from the patients' respiratory tract [65]. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32360444-16778260-22369804 | 513-515 | 16778260 | denotes | 64 |
32360444-29161116-22369805 | 888-890 | 29161116 | denotes | 65 |